Intervention Review

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

  1. Shelley R Salpeter1,*,
  2. Elizabeth Greyber2,
  3. Gary A Pasternak2,
  4. Edwin E Salpeter3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 14 APR 2010

Assessed as up-to-date: 7 OCT 2009

DOI: 10.1002/14651858.CD002967.pub4

How to Cite

Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD002967. DOI: 10.1002/14651858.CD002967.pub4.

Author Information

  1. 1

    Stanford University, and Santa Clara Valley Medical Center, Medicine, San Jose, CA, USA

  2. 2

    Santa Clara Valley Medical Center, Medicine, San Jose, CA, USA

  3. 3

    Cornell University, Center for Radiophysics and Space Research, Ithaca, NY, USA

*Shelley R Salpeter, Medicine, Stanford University, and Santa Clara Valley Medical Center, 2400 Moorpark Ave, Suite 118, San Jose, CA, 95128, USA. salpeter@stanford.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 14 APR 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >